Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight.
Schöndorf T, Forst T, Hohberg C, Pahler S, Link C, Roth W, Pfützner A, Lübben G, Link C, Pfützner A. Schöndorf T, et al. Among authors: pfutzner a. Diabetes Obes Metab. 2007 Jan;9(1):132-3. doi: 10.1111/j.1463-1326.2006.00582.x. Diabetes Obes Metab. 2007. PMID: 17199730 Clinical Trial. No abstract available.
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.
Schöndorf T, Karagiannis E, Posseldt RE, Forst T, Pfützner A. Schöndorf T, et al. Among authors: pfutzner a. Diabetes Technol Ther. 2009 Jun;11(6):379-83. doi: 10.1089/dia.2008.0108. Diabetes Technol Ther. 2009. PMID: 19459767
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.
Schöndorf T, Musholt PB, Hohberg C, Forst T, Lehmann U, Fuchs W, Löbig M, Müller J, Pfützner A. Schöndorf T, et al. Among authors: pfutzner a. J Diabetes Sci Technol. 2011 Mar 1;5(2):426-32. doi: 10.1177/193229681100500233. J Diabetes Sci Technol. 2011. PMID: 21527115 Free PMC article. Clinical Trial.
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
Forst T, Pfützner A, Lübben G, Weber M, Marx N, Karagiannis E, Koehler C, Baurecht W, Hohberg C, Hanefeld M. Forst T, et al. Among authors: pfutzner a. Metabolism. 2007 Apr;56(4):491-6. doi: 10.1016/j.metabol.2006.11.007. Metabolism. 2007. PMID: 17379006 Clinical Trial.
282 results